The Texas Children’s Hospital (TCH) and Baylor College of Medicine (BCM) announced that Corbevax, a protein subunit Covid vaccine, has received approval from the Drugs Controller General of India (DCGI) to launch it in India. The initial construct and production process of the vaccine antigen was developed at TCH’s Centre for Vaccine Development.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
As Corbevax has been granted emergency use authorisation in India, Professor Peter Hotez said, “given the urgency, Corbevax will be helpful not only for India but globally as most of the African continent, neighbouring countries around India remain largely unvaccinated.” Emergency use authorisation of Corbevax in India for adults 18 and older will have a great pediatric profile because parents have been giving the same technology (as in vaccine) to their kids for decades.
Important takeaways for all competitive exams:
Did you know that one of the most important waterways in the world plays a…
Did you know that not all airlines are judged the same way? Some are ranked…
As escalating tensions between the US - Israel - Iran conflict the Philippines has declared…
S&P Global Ratings on March 25, 2026 has updated and raised the India's GDP growth…
For India's space technology boost the Akasha300 3D printer which is developed by Kerala-based startup…
OpenAI has appointed Kiran Mani who is the former CEO of JioStar as the Managing…